| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 8 | +87.50% | -4.88% | +0.74% | -5.62% | -10.26% | — |
| 14d | 8 | +87.50% | -10.21% | +0.55% | -10.76% | -20.37% | — |
| 30d | 8 | +75.00% | -9.80% | +3.40% | -13.21% | -20.48% | — |
| 60d | 8 | +87.50% | -4.29% | +4.69% | -8.98% | -21.77% | — |
| 90d | 8 | +62.50% | +2.55% | +7.05% | -4.50% | -7.66% | — |
| 180d | 8 | +75.00% | -1.72% | +11.23% | -12.95% | -24.71% | — |
| 1y | 8 | +12.50% | +38.70% | +10.10% | +7.96% | -6.28% | — |
| 2y | 8(5 pending) | +66.67% | +37.82% | +21.25% | +16.57% | -0.34% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ETON ETON PHARMACEUTICALS, INC. | SALE President & CEO | 148 | $32.67 | $4.8K | 833,694 | May 28, 2026 | May 29, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE President & CEO | 119,852 | $31.88 | $3.82M | 833,842 | May 28, 2026 | May 29, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 158,046 | — | — | 3,047,312 | Jan 12, 2026 | Jan 14, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 100,517 | — | — | 3,147,829 | Jan 12, 2026 | Jan 14, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE President & CEO | 5,015 | $15.39 | $77.2K | 2,889,266 | Jan 1, 2026 | Jan 14, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE President & CEO | 6,732 | $16.83 | $113.3K | 2,894,281 | Dec 12, 2025 | Dec 12, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE President & CEO | 70,000 | $16.81 | $1.18M | 2,873,513 | Jun 5, 2025 | Jun 5, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE President & CEO | 70,000 | $17.00 | $1.19M | 2,943,513 | Jun 4, 2025 | Jun 5, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE President & CEO | 400 | $19.02 | $7.6K | 3,013,513 | Jun 3, 2025 | Jun 5, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE President & CEO | 60,945 | $17.38 | $1.06M | 3,022,568 | Jun 3, 2025 | Jun 5, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE President & CEO | 8,655 | $18.38 | $159.1K | 3,013,913 | Jun 3, 2025 | Jun 5, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 72,004 | — | — | 72,004 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 107,469 | — | — | 107,469 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 438,633 | — | — | 2,473,014 | Feb 13, 2024 | Feb 15, 2024 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 350,381 | — | — | 1,951,881 | Mar 3, 2023 | Mar 3, 2023 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 10,000 | $2.10 | $21.0K | 1,040,000 | Sep 22, 2022 | Sep 23, 2022 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 110,000 | — | — | 110,000 | Jul 12, 2022 | Jul 18, 2022 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 416,500 | — | — | 1,601,500 | Feb 7, 2022 | Feb 28, 2022 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASE President & CEO | 10,000 | $4.32 | $43.2K | 1,030,000 | Aug 20, 2021 | Aug 20, 2021 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASE President & CEO | 5,000 | $5.96 | $29.8K | 1,030,000 | Jun 3, 2021 | Jun 3, 2021 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 245,000 | — | — | 1,185,000 | May 3, 2021 | May 5, 2021 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 490,000 | — | — | 490,000 | Mar 12, 2020 | Mar 16, 2020 ↗ | View → |